HOME
Hepatitis B
HIV and AIDS
Hepatitis C
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV
and
Hepatitis
.com
HIV and AIDS Topics
Top News Articles
FDA-approved Treatments
Experimental Treatments
Treatment Guidelines
Adverse Events
Lipodystrophy
Women / Children
Metabolic Complications
Opportunistic Infections
Glossary of HIV/AIDS-related Terms
Opportunistic Infections
Amphotericin B Alone or with Fluconazole (Diflucan) for Treatment of
HIV-related Cryptococcal Meningitis
6
-
19
-
2009
TB Alliance and Tibotec Form Collaboration to Develop
New Drugs for Tuberculosis
6
-
19
-
2009
Promising Interim Results of a Study of TMC207, a New Experimental Drug for Treatment of Multidrug-resistant
Tuberculosis (MDR-TB)
6
-
5
-
2009
Early Antiretroviral Therapy
Reduces Disease Progression and Death in HIV Patients with Opportunistic Infections
5
-
29-2009
CDC Issues
Flu Treatment Guidelines
and Public Health Service Updates Antiretroviral Therapy Recommendations for Pregnant Women with HIV
5
-
29-2009
H1N1 Swine Flu Update
and CDC Interim Guidance for Clinicians Treating People with HIV
5/05/09
U.S. Declares Public Health Emergency as
Swine Flu
Outbreak Spreads
4/28/09
Newly Updated Guidelines for Prevention and Treatment of HIV-related
Opportunistic Infections
4/21/09
Some AIDS-defining
Opportunistic Illnesses
Remain a Significant Cause of Death in the HAART Era
4/21/09
WHO Releases New Report on
Tuberculosis
and Its Impact on People with HIV/AIDS
3/31/09
Preventive Isoniazid plus HAART Lowers the Risk of Active
Tuberculosis
among HIV Patients by 89%
3/31/09
WHO Releases
New Report on Tuberculosis
and Its Impact on People with HIV/AIDS
3/27/09
Preventive Isoniazid plus HAART Lowers the Risk of Active
Tuberculosis
among HIV Patients by 89%
3/27/09
Protease Inhibitors
Agenerase
(amprenavir)
Aptivus
(tipranavir)
Crixivan
(indinavir)
Invirase
(saquinavir hard gel)
Kaletra
(lopinavir/ritonavir)
Lexiva
(fosamprenavir)
Norvir
(ritonavir)
Prezista
(darunavir)
Reyataz
(atazanavir)
Viracept
(nelfinavir)
Nucleo
side /
Nucleo
tide
Reverse
Transcriptase Inhibitors
Combivir
(zidovudine/lamivudine)
Epivir
(lamivudine; 3TC)
Emtriva
(emtricitabine; FTC)
Epzicom
(abacavir + lamivudine)
Retrovir
(zidovudine; AZT)
Trizivir
(abacavir + zidovudine +lamivudine)
Truvada
(tenofovir / emtricitabine)
Videx
(didanosine; ddI)
Viread
(tenofovir)
Zerit
(stavudine; d4T)
Ziagen
(abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine
(Intelence; TMC125)
Rescriptor
(delavirdine)
Sustiva
(efavirenz)
Viramune
(nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon
(enfuvirtide, T-20)
Selzentry
(maraviroc)
Fixed Dose Combinations
Atripla
(efavirenz + emtricitabine + tenofovir)
Combivir
(zidovudine + lamivudine)
Trizivir
(abacavir + zidovudine + lamivudine)
Truvada
(tenofovir + emtricitabine)
Integrase Inhibitor
Isentress
(raltegravir)